Comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 vs 1p21 3 Microdeletion Syndrome
Clinical comparison between 3 Beta Hydroxysteroid Dehydrogenase Deficiency and 1p21 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
6 comparison axes
Onset
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
0-null
1p21 3 Microdeletion Syndrome
0-null
Onset patterns differ
Severity
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
severe
1p21 3 Microdeletion Syndrome
moderate
Different severity levels
Chronic
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
Chronic
1p21 3 Microdeletion Syndrome
Chronic
Differing course
Communicable
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
No
1p21 3 Microdeletion Syndrome
No
Different transmission
Body System
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
1p21 3 Microdeletion Syndrome
congenital
Same/different system
Category
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
endocrine
1p21 3 Microdeletion Syndrome
genetic
Different category
Bottom line
3-beta-hydroxysteroid-dehydrogenase-deficiency-C0342471 and 1p21-3-microdeletion-syndrome-C4304578 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 1p21 3 Microdeletion Syndrome | Discriminating power |
|---|---|---|---|
| Primary clinical domain | Disordered adrenal and gonadal steroid production, sometimes with salt wasting or atypical genitalia. | A chromosomal copy-number finding; a specific symptom pattern is not established here. | High |
| Acute decompensation | Possible salt-wasting crisis with dehydration or shock, especially in infancy. | No adrenal crisis is established from the supplied description. | High |
| Developmental features | Not primarily defined as a neurodevelopmental syndrome in the source. | Developmental effects may occur with microdeletions, but none are specified here. | Moderate |
When to favor each condition
Choose 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 when
Infant with suspected adrenal insufficiency
Salt wasting and steroid imbalance point toward an adrenal enzyme disorder.
High
Atypical genitalia with hormonal imbalance
Disordered sex-steroid synthesis is a recognized feature of this deficiency.
Moderate
Abnormal steroid pathway testing
A compatible steroid pattern supports specialist endocrine evaluation; cutoffs are not supplied.
Moderate
Choose 1p21 3 Microdeletion Syndrome when
Microarray reports a 1p21.3 deletion
The chromosomal result itself directs genetic rather than endocrine classification.
High
Unexplained congenital or developmental concerns
Chromosomal testing may be relevant, but this source does not define the phenotype.
Low
No biochemical adrenal abnormality
Absence of steroid dysfunction makes the enzyme deficiency less likely, without proving the deletion syndrome.
Moderate
How key tests differ
| Test | 3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471 | 1p21 3 Microdeletion Syndrome | Interpretation |
|---|---|---|---|
| Steroid hormone profile | Pattern suggesting impaired 3β-hydroxysteroid dehydrogenase activity; exact cutoffs not supplied. | No characteristic endocrine pattern is established. | An abnormal profile is a finding requiring endocrine confirmation, not a standalone diagnosis. |
| Serum electrolytes | Salt wasting may cause low sodium and high potassium. | No electrolyte abnormality is established from the source. | Electrolyte changes support urgent adrenal assessment but are not specific. |
| Chromosomal microarray | Not the test that establishes this enzyme deficiency. | May identify a 1p21.3 copy-number loss. | A deletion is a genetic finding whose clinical significance needs genetics review. |
Prognosis comparison
3 Beta Hydroxysteroid Dehydrogenase Deficiency C0342471
- Outcome
- Potentially serious, especially with unrecognized salt wasting; many outcomes depend on timely care.
- Factors
- Severity, salt wasting, age at recognition, and response to specialist management.
1p21 3 Microdeletion Syndrome
- Outcome
- Prognosis is not established from the supplied source.
- Factors
- Deletion size, involved genes, and individual clinical findings are not provided.
Time frame: Both may be lifelong considerations; no mortality or timeline is established here.
Accurate diagnosis, associated anomalies, and access to specialist monitoring.
Complications comparison
| Complication | Presentation |
|---|---|
| Salt-wasting crisis | Recognized potential emergency. Not established in the supplied data. Suspected crisis needs urgent clinical care; no treatment doses are provided. |
| Hormonal imbalance | May affect sex development and adrenal hormones. No specific hormonal complication is described. Management and monitoring should be individualized by specialists. |
| Neurodevelopmental impact | Not established as a core feature here. Possible in principle but unspecified for this deletion. Do not infer developmental outcome without clinical and genetic assessment. |
Patient education highlights
- HighUrgent warning signs
Poor feeding, vomiting, dehydration, or collapse in a suspected adrenal disorder needs emergency care.
- HighResult versus diagnosis
An abnormal hormone result or microarray finding requires clinician interpretation before being called a diagnosis.
- MediumLong-term follow-up
Endocrine or genetics follow-up may be needed; exact therapy cannot be determined from this comparison.